Want to see TSE:CDVA full AI Analyst Report?
CordovaCann (CDVA) AI Stock Analysis
CordovaCann
(CNQX:CDVA)
The overall score is severely constrained by a distressed balance sheet with negative equity, signaling potential insolvency. While the company generates positive operating cash flow and has improved EBITDA, these operational strengths are overshadowed by the fundamental financial risk. Technical trends are bearish, and the negative P/E ratio confirms a lack of bottom-line profitability.
CordovaCann (CDVA) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 3.29M
- Dividend Yield
- ―
- Average Volume (3M)
- 32.57K
- Price to Earnings (P/E)
- -1.0
- Beta (1Y)
- 4.40
- Revenue Growth
- -6.27%
- EPS Growth
- 44.49%
- Country
- Canada
- Employees
- 45
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
CordovaCann Business Overview & Revenue Model
Company Description
CordovaCann Corp. is a company that focuses on various aspects of the cannabis industry, including identifying prospects, securing financing, developing new ventures, and managing operations throughout the entire cannabis value chain. As of February...
CordovaCann Financial Statement Overview
Summary
Financial performance is deeply divided. Operational improvements are evident with positive EBITDA and operating cash flow, but the balance sheet is in distress with negative stockholders' equity of -$7.5M, indicating insolvency risk. The income statement score of 35 and balance sheet score of 8 heavily drag down the overall financial health, despite a decent cash flow score of 65.
Income Statement
35NegativeBalance Sheet
8Very NegativeCash Flow
65Positive| Breakdown | TTM | Jun 2026 | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.72M | 13.36M | 14.25M | 13.80M | 13.59M | 13.53M |
| Gross Profit | 1.83M | 1.82M | 1.55M | 4.08M | 3.86M | 3.73M |
| EBITDA | -1.04M | 895.86K | -817.35K | 493.74K | -4.68M | -1.85M |
| Net Income | -2.64M | -1.49M | -2.69M | -1.49M | -6.88M | -3.96M |
Balance Sheet | ||||||
| Total Assets | 6.38M | 5.81M | 6.41M | 9.55M | 10.26M | 16.75M |
| Cash, Cash Equivalents and Short-Term Investments | 515.15K | 493.53K | 598.20K | 552.47K | 248.42K | 714.83K |
| Total Debt | 5.17M | 5.70M | 5.00M | 6.21M | 6.38M | 6.08M |
| Total Liabilities | 12.13M | 12.86M | 11.61M | 12.15M | 11.29M | 10.16M |
| Stockholders Equity | -6.24M | -7.54M | -5.81M | -3.30M | -1.72M | 5.86M |
Cash Flow | ||||||
| Free Cash Flow | 906.77K | 1.14M | 1.12M | 1.49M | -1.21M | -2.73M |
| Operating Cash Flow | 923.45K | 1.14M | 1.14M | 1.49M | -452.73K | -2.07M |
| Investing Cash Flow | 1.55M | 0 | 1.55M | 52.96K | -708.88K | 2.07M |
| Financing Cash Flow | -2.49M | -1.01M | -2.51M | -1.10M | -134.36K | 720.69K |
CordovaCann Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CDVA, the sentiment is Negative. The current price of 0.03 is above the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.03, and below the 200-day MA of 0.03, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 38.46 is Neutral, neither overbought nor oversold. The STOCH value of 0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CDVA.
CordovaCann Risk Analysis
CordovaCann disclosed 43 risk factors in its most recent earnings report. CordovaCann reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksCordovaCann Peers Comparison
Overall Rating
TSE:BBM45Neutral- TSE:CDVA41Neutral
TSE:CVGR41Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| TSE:BBM | 45Neutral | CAD 7.43M | -7.14 | -332.63% | ― | -36.67% | 40.54% |
| TSE:CDVA | 41Neutral | CAD 2.75M | -1.04 | 43.99% | ― | -6.27% | 44.49% |
| TSE:CVGR | 41Neutral | CAD 2.32M | -1.69 | 64.32% | ― | ― | -26.62% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:CDVA | CordovaCann Corp | 0.03 | -0.00 | -16.67% | |
| TSE:BBM | Blueberries Medical | 0.01 | -0.01 | -25.00% | |
| TSE:BAMM | Body & Mind | 0.03 | 0.00 | 0.00% | |
| TSE:CVGR | City View Green Holdings, Inc. | 0.03 | -0.04 | -53.85% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 02, 2026